STOCK TITAN

Art's-Way Manufacturing SEC Filings

ARTW NASDAQ

Welcome to our dedicated page for Art's-Way Manufacturing SEC filings (Ticker: ARTW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Art's-Way Manufacturing Co., Inc. filings document operating results, segment performance, governance matters, and shareholder voting for the agricultural equipment and modular buildings manufacturer. Form 8-K reports include results of operations and financial condition for quarterly and fiscal periods, with disclosures tied to Agricultural Products, Modular Buildings, continuing operations, and the completed wind-down of the former Tools segment.

Proxy and annual-meeting filings cover board elections, auditor ratification, advisory executive-compensation votes, equity-award disclosures, and amendments to the 2020 Equity Incentive Plan. The company's filing record also documents shareholder-vote frequency decisions and related governance procedures.

Rhea-AI Summary

Art's Way Manufacturing Co., Inc. reported that director Randall C. Ramsey received a grant of 1,000 shares of common stock on 11/30/2025. The award consists of fully vested restricted stock issued under the company’s director compensation plan at a stated price of $0 per share.

Following this grant, Ramsey directly beneficially owned 73,709 shares of Art's Way Manufacturing common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Arts Way Manufacturing director David A. White reported acquiring 1,000 shares of common stock on 11/30/2025. The transaction was listed as an acquisition at a stated price of $0.

The shares are described as fully-vested restricted stock granted under the director compensation plan. Following this award, White beneficially owns 46,000 shares of Arts Way common stock in direct form.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Art’s-Way Manufacturing (ARTW) reported Q3 2025 results. Sales were $6,432,296 with gross margin of 27.5%, and net income from continuing operations was $254,110 ($0.05 per share). Year-to-date, sales were $17,909,941 and net income from continuing operations reached $1,680,423 ($0.33 per share). Results benefited from Employee Retention Credit refunds recorded in other income of $1,620,103 and $246,108 of interest, offset by $405,026 of consulting fees.

Segment trends diverged: Modular Buildings delivered Q3 revenue of $3,449,000 and 35.4% gross margin, while Agricultural Products posted $2,983,000 and 18.3% margin. Cash was $5,960; inventories were $11,237,942. The revolving line of credit balance was $2,672,437 (7.5% rate) with $1,327,563 remaining available. Term debt totaled $2,006,259, including a 7.00% Bank Midwest loan and two SBA EIDL loans at 3.75%. Subsequent to quarter-end, the company entered a $516,971 roof loan at 7.25%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
Rhea-AI Summary

Art's-Way Manufacturing Co., Inc. filed a Current Report stating that it issued a press release announcing its financial results for the three- and nine-month periods ended August 31, 2025. The filing notes that the full press release text appears as Exhibit 99.1 and is incorporated by reference into the report. No financial statements, pro forma information, or shell company transactions are included in the filing itself.

The Item identifies the press release as the source of the announced results but clarifies that the information in Item 2.02 and Exhibit 99.1 is not being "filed" for Section 18 liability purposes and will not be incorporated by reference into registration statements unless specifically stated. The report is signed by the company’s Chief Financial Officer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Marc H. McConnell, who serves as President, CEO, Chairman and a director of Arts-Way Manufacturing Co., reported a purchase of 1,000 shares of Common Stock on 08/31/2025 under the director compensation plan as fully vested restricted stock. The Form 4 shows 220,500 shares reported as beneficially owned directly following the transaction and several indirect holdings: 5,580 shares held via an IRA, 5,000 shares held for each of two children, and 2,149,819 shares held indirectly through McConnell Legacy Investments, LLC, of which he is Managing Member. The filing also details multiple restricted-stock tranches subject to staggered vesting dates in 2026 and 2027–2028.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

David A. White, a director of Arts-Way Manufacturing Co Inc (ARTW), received a grant of 1,000 fully-vested restricted shares on 08/31/2025 under the companys director compensation plan. The grant was recorded at a transaction price of $0 and increased his reported beneficial ownership to 45,000 shares. The Form 4 was signed by an attorney-in-fact for Mr. White on 08/31/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Matthew Westendorf, a director of Arts-Way Manufacturing Co Inc (ARTW), was granted 1,000 fully-vested restricted shares on 08/31/2025 at a reported price of $0 under the director compensation plan. Following the award, Westendorf's beneficial ownership increased to 26,000 shares. The Form 4 was filed as a single reporting person filing and was signed by an attorney-in-fact.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Randall C. Ramsey, a director of Arts-Way Manufacturing Co., received 1,000 fully vested restricted shares on 08/31/2025 under the company's director compensation plan. The transaction was reported on a Form 4 filed pursuant to Section 16. Following the grant, Mr. Ramsey beneficially owns 72,709 shares of the issuer's common stock, held in a direct capacity.

The reported shares were granted at a $0 purchase price and are described as fully vested restricted stock. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Ramsey and contains an explanation that the award represents director compensation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Thomas E. Buffamante, a director of Arts-Way Manufacturing Co., acquired 1,000 shares of common stock on 08/31/2025 as fully-vested restricted stock under the company's director compensation plan. The transaction shows a $0 price for the grant and increases his beneficial ownership to 58,000 shares, reported as direct ownership. The Form 4 was filed by a single reporting person and signed by an attorney-in-fact on the same date. The filing does not disclose derivative transactions, amendments, or additional cash consideration.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Art’s-Way Manufacturing Co., Inc. filed an amendment to update governance information from its 2025 Annual Meeting of Stockholders. The Board of Directors has decided that stockholders will continue to cast non-binding, advisory votes on the compensation of the company’s named executive officers every year.

This decision follows the stockholders’ prior non-binding recommendation in favor of an annual “say-on-pay” frequency and is consistent with the company’s earlier proxy recommendation. The company states that this annual advisory vote schedule will remain in place until the next required stockholder vote on frequency, which must occur no later than the 2031 Annual Meeting of Stockholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Art’s-Way Manufacturing Co., Inc. filed an amendment to update governance information from its 2025 Annual Meeting of Stockholders. The Board of Directors has decided that stockholders will continue to cast non-binding, advisory votes on the compensation of the company’s named executive officers every year.

This decision follows the stockholders’ prior non-binding recommendation in favor of an annual “say-on-pay” frequency and is consistent with the company’s earlier proxy recommendation. The company states that this annual advisory vote schedule will remain in place until the next required stockholder vote on frequency, which must occur no later than the 2031 Annual Meeting of Stockholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

How many Art's-Way Manufacturing (ARTW) SEC filings are available on StockTitan?

StockTitan tracks 46 SEC filings for Art's-Way Manufacturing (ARTW), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Art's-Way Manufacturing (ARTW)?

The most recent SEC filing for Art's-Way Manufacturing (ARTW) was filed on December 15, 2025.